Shijiazhuang Yiling Pharmaceutical Co Ltd
SZSE:002603

Watchlist Manager
Shijiazhuang Yiling Pharmaceutical Co Ltd Logo
Shijiazhuang Yiling Pharmaceutical Co Ltd
SZSE:002603
Watchlist
Price: 17.07 CNY 0.41% Market Closed
Market Cap: 28.5B CNY
Have any thoughts about
Shijiazhuang Yiling Pharmaceutical Co Ltd?
Write Note

Shijiazhuang Yiling Pharmaceutical Co Ltd
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Shijiazhuang Yiling Pharmaceutical Co Ltd
Accounts Payable Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Shijiazhuang Yiling Pharmaceutical Co Ltd
SZSE:002603
Accounts Payable
ÂĄ1.9B
CAGR 3-Years
11%
CAGR 5-Years
31%
CAGR 10-Years
24%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Accounts Payable
ÂĄ163.8m
CAGR 3-Years
10%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Accounts Payable
ÂĄ470.9m
CAGR 3-Years
19%
CAGR 5-Years
16%
CAGR 10-Years
20%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Accounts Payable
ÂĄ1.4B
CAGR 3-Years
9%
CAGR 5-Years
0%
CAGR 10-Years
17%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Accounts Payable
ÂĄ4.5B
CAGR 3-Years
3%
CAGR 5-Years
0%
CAGR 10-Years
8%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Accounts Payable
ÂĄ307.9m
CAGR 3-Years
65%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Shijiazhuang Yiling Pharmaceutical Co Ltd's Accounts Payable?
Accounts Payable
1.9B CNY

Based on the financial report for Jun 30, 2024, Shijiazhuang Yiling Pharmaceutical Co Ltd's Accounts Payable amounts to 1.9B CNY.

What is Shijiazhuang Yiling Pharmaceutical Co Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
24%

Over the last year, the Accounts Payable growth was -16%. The average annual Accounts Payable growth rates for Shijiazhuang Yiling Pharmaceutical Co Ltd have been 11% over the past three years , 31% over the past five years , and 24% over the past ten years .

Back to Top